FDA CDER - Umen & Co. Drug and Medical Device Regulatory Strategy and Medical Writing
ICH - Umen & Co.
 Umen & Co. Home About Us Services Why Umen & Co. Umen & Co. Team Umen & Co. White Papers Contact Umen & Co.
 

 

Having contributed
to approximately
15-20%
of the drugs
approved in the
past three decades…

…we are the experts.

 

 

 

 

 

Drug and Medical Device Regulatory Strategy and Medical WritingUmen & Co. provides strategic regulatory consulting and medical writing services to the pharmaceutical and biotech industries. Our core strength lies in combining these two capabilities to create documents that are objective, persuasive, and supportive of labeling. We assist clients in preparing various NDA/BLA documents and in projects ranging from pre-IND information packages to post-approval supplements.

 

Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template
by Mary Vanderhoof, MS
Michael J. Umen, PhD
David N. Schwartz, BS
As printed in Drug Information Journal, Vol. 42, pp. 349-357, 2008.
Adobe Reader

Read Full Article
(requires Adobe Reader)

 

Umen & Co.  The Leader in NDA Preparation Since 1981